Navigation Links
International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
Date:9/27/2007

. regulatory authorities. ''Our ultimate goal is to see NeuroAid(TM) included in key treatment guidelines for stroke victims, making its benefits available to all patients who need it,'' David added.

NeuroAid(TM)'s efficacy and safety was tested in a multi-centre double blind randomized clinical trial conducted on 605 patients in China in 1999- 2000. Patients taking NeuroAid(TM) were shown to be 2.11 times more likely to reach functional independence and 1.7 times more likely to reduce their neurological deficit by at least 55% than patients who did not take the product. It helped improve stroke patients' ability to recover even when treatment was started several weeks after the onset of stroke.

About NeuroAid(TM)

NeuroAid(TM) is a Traditional Chinese Medicine that provides faster and more extensive recovery of motor and cognitive functions in stroke patients during rehabilitation. It is a combination of fourteen all-natural ingredients from the Chinese medicinal pharmacopoeia, formulated according to international Good Manufacturing Practice (GMP) standards. It is marketed internationally by Moleac, the biopharmaceutical company that identified the product in China as the first medicine to help improve stroke recovery. NeuroAid(TM) is currently marketed in Singapore as a Chinese proprietary medicine, and in other countries in the region as a dietary supplement. It is also sold internationally by Moleac via the website http://www.neuroaid.com . With the CHIMES study, NeuroAid(TM) is the first traditional medicine in the world to be studied in a large scale evidence-based clinical trial.

About Moleac

Moleac is a biopharmaceutical company based in Biopolis, a world-class purpose built complex for biomedical sciences research in Singapore ( http://www.biopolis.com.sg ). Moleac identifies promising medicines discovered in China and dev
'/>"/>

SOURCE Moleac
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Nov. 25 Hologic, Inc. (...g developer, manufacturer and supplier of premium ...products dedicated to serving the healthcare needs...ological Society of North America (RSNA) at McCorm... 3, 2009 to highlight our new SecurView(®) DX...
(Date:11/25/2009)...Nov. 25 The FDA granted traditiona...s, a non-nucleoside reverse transcriptase inhibito...y indicated for use in treatment-experienced adult...1 strains resistant to an NNRTI and other antiretr...based on 48-week data from two Phase 3 studies kno...
(Date:11/25/2009)...hina, Nov. 25 /PRNewswire-Asia-FirstCall/ -- China... "the Company") (Nasdaq: CSKI ), a,leading fully ...roducing,over-the-counter drugs in the People,s Re...Company recently passed the Chinese National Insti...cal Products ("ICPBP") examination,for two of its ...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3NEJM study addresses impact of Medicare Part D on medical spending 50721 1NEJM study addresses impact of Medicare Part D on medical spending 50721 2Study in Nature 3A MicroRNAs hold promise for treating diseases in blood vessels 50718 1Study in Nature 3A MicroRNAs hold promise for treating diseases in blood vessels 50718 2Study in Nature 3A MicroRNAs hold promise for treating diseases in blood vessels 50718 3Study in Nature 3A MicroRNAs hold promise for treating diseases in blood vessels 50718 4Kids May Learn to Tolerate Food Allergens 50716 1Kids May Learn to Tolerate Food Allergens 50716 2Kids May Learn to Tolerate Food Allergens 50716 3
...tient trial show those treated with,Prexige experi...re,compared to ibuprofen[1] , * Many patients with...n small changes in blood pressure can impact,cardi... than 50 countries and currently under,review in U...zerland, June 15, 2007 - Patients with osteoarthri...
...y Showed 11 Percent Fewer RA Patients,Reported Job...,Compared to Methotrexate Alone, BARCELONA, Spain,...d arthritis (RA) is one of the most common causes ...sed today show that,rheumatoid arthritis (RA) pati...stayed working longer, had fewer absences and repo...
Other Medicine Technology:Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7
(Date:11/30/2009)... How about a stocking stuffer that saves li...Super-Reflective POP BANDS® , Pet Collars and... unique, and fun gifts that make a difference. , ...er 30, 2009 -- How would you like to give a gift t...year?, , , , ,Vedante,s super-reflective POP BAND...
(Date:11/30/2009)... Firm uses Staten Island courtroom to recre...nts were 100% responsible for client’s accid...xis) November 30, 2009 -- A Staten Island, N.Y. ju...on paperhanger who was injured at a New York City ...i v. J.T. Magen Construction Company et al (Index ...
(Date:11/30/2009)...OOK, Ill. and PLYMOUTH MEETING, Pa., Nov. 30 /PRNe...(UHC) today announced that it has signed an agreem... Pa, to offer its academic medical center members ...ology research. This agreement will offer UHC memb...RI Institute, an independent nonprofit organizatio...
(Date:11/30/2009)...ecades ago, a study revealed that beverage can pul... a switch by U.S. manufacturers to stay-tabs. But ...he Radiological Society of North America (RSNA) fo.... , "One of the driving factors leading the chan... eliminate inadvertent swallowing of the pull-tab ...
(Date:11/29/2009)...eaths from cancer in Europe show a steady decline ...0-2004. Deaths from all cancers in the European Un...rcent in men and eight percent in women, with a la... a study published online in the cancer journal, ..., researchers found that there was an average 185....
Breaking Medicine News(10 mins):Health News:Fun and Fashionable Holiday Gifts that Save Lives 2Health News:Fun and Fashionable Holiday Gifts that Save Lives 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 4Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 3Health News:Beverage can stay-tabs pose swallowing risk 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 4Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 5
...stems (Nasdaq: MEDW ) announced today that Univer...orial Hospital have implemented and are live,using...re system. More than,300 top tier healthcare facil...of these facilities were live. Mediware has provi...
..., LLC,announced today that it has issued an Execut... Pharmaceuticals, Inc. (Nasdaq: TPPH ). The full ...ra.com . Tapestry Pharmaceuticals, Inc. ("Tapestr...e Company,s lead,compound, TPI 287, is a novel, pr...
...ievement in applied medical ...ns Medical,Solutions (http://www.usa.siemens.com/..., chief medical information officer, Catholic Heal...recognizes,individuals for excellence and outstand...
...omprehensive Ever, NEW YORK, Sept. 11 A new revi... ever conducted -- once again has concluded the,wi... heaviest users. The review, "Aspartame: A Safety...thcare,s Critical Reviews,in Toxicology (Volume 37...
...patients in publicly funded community health cente...services outside of these centers, a new study fin...or has determined that the patient does in fact ne...es, people think that community health centers act...
...ty vegetables can reduce asthma and allergies, acc...en, published in the September issue of Pediatric ...force the researchers earlier findings that a fish...t of a childs diet on asthma and allergies and als...
Other Medicine News:Health News:Additional Top Tier Institutions Implement Mediware's HCLL(TM) Transfusion Management Software 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 3Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 2Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 3Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 4Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 2Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 3Health News:Uninsured community health center patients often have difficulty accessing specialty services 2Health News:Uninsured community health center patients often have difficulty accessing specialty services 3Health News:'Fruity vegetables' and fish reduce asthma and allergies 2
Bard® Channel Drain
Spencer Modified Biliary Wire Guides
Common Duct Exploration Set: With N-Circle® Nitinol Tipless Stone Extractor
MAMMOTOME® HH (Hand Held): 8 Gauge Probe
Medicine Products: